Stay tuned, registration will open soon!
About the Conference:
ESH Translational Research Conferences focus on leading-edge basic, clinical and therapeutic research and future perspectives.
The presentation of unpublished data is encouraged.
This leading-edge translational research conference will address the rapidly evolving field of lymphoid malignancies, including T- and B-cell lymphomas, and chronic lymphocytic leukaemia (CLL), from molecular pathogenesis to state-of-the-art treatment and future perspectives.
The goals of this conference are to:
- foster scientific exchange between laboratory scientists and clinicians working on lymphoid malignancies worldwide.
- foster scientific cross-fertilization between researchers and clinicians working on different diseases with partially overlapping pathogenic mechanisms such as the B cell receptor signaling, alterations of the DNA damage response, or the increasingly important dialogue of lymphoid tumour cells with their microenvironment.
- provide opportunities for leading-edge education and international networking to basic and clinical scientists, including those still in-training
A first-class selection of international speakers will guarantee the highest quality of science and a summary of the most recent developments in the biology and therapy of Lymphoid Malignancies.
The programme will include:
Plenary Sessions - Simultaneous Meet the Experts Sessions
Round Table Discussions - Brief Oral Communications
Mentored Poster Walk - Ample time for in-depth discussion
For more information, click here!